NovoCure Ltd (NVCR): Shares Outstanding
112.49M
As of 2025-12-31
116.44M
As of 2026-06-30
+2.3%
3-year compound annual growth
+1.9%
5-year compound annual growth
+3.0%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 112.49M | +3.7% | 2026-02-26, Balance as of period end |
| 2024-12-31 | 108.52M | +1.3% | 2026-02-26, Balance as of period end |
| 2023-12-31 | 107.08M | +1.9% | 2025-02-27, Balance as of period end |
| 2022-12-31 | 105.05M | +1.0% | 2024-02-22, Balance as of period end |
| 2021-12-31 | 103.97M | +1.6% | 2023-02-23, Balance as of period end |
| 2020-12-31 | 102.33M | +2.8% | 2022-02-24, Balance as of period end |
| 2019-12-31 | 99.53M | +6.7% | 2021-02-25, Balance as of period end |
| 2018-12-31 | 93.25M | +4.2% | 2020-02-27, Balance as of period end |
| 2017-12-31 | 89.48M | +2.8% | 2019-02-28, Balance as of period end |
| 2016-12-31 | 87.07M | +3.9% | 2018-02-22, Balance as of period end |
| 2015-12-31 | 83.78M | +523.8% | 2017-02-23, Balance as of period end |
| 2014-12-31 | 13.43M | n/a | 2016-03-01, Balance as of period end |